1. Home
  2. LODE vs ANIK Comparison

LODE vs ANIK Comparison

Compare LODE & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

N/A

Current Price

$2.27

Market Cap

171.0M

Sector

Industrials

ML Signal

N/A

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

N/A

Current Price

$19.34

Market Cap

200.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LODE
ANIK
Founded
1999
1983
Country
United States
United States
Employees
45
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.0M
200.9M
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
LODE
ANIK
Price
$2.27
$19.34
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $22.00
AVG Volume (30 Days)
★ 1.2M
59.8K
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
63.55
★ 80.16
EPS
N/A
★ N/A
Revenue
$1,553,796.00
★ $112,819,000.00
Revenue This Year
$303.79
$7.82
Revenue Next Year
$410.04
$5.44
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.23
$8.67
52 Week High
$4.98
$22.88

Technical Indicators

Market Signals
Indicator
LODE
ANIK
Relative Strength Index (RSI) 27.65 38.33
Support Level N/A $13.88
Resistance Level $3.61 $22.70
Average True Range (ATR) 0.17 0.60
MACD -0.02 -0.22
Stochastic Oscillator 17.21 6.76

Price Performance

Historical Comparison
LODE
ANIK

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: